← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alphavax Human Vaccines, Inc.
Research Triangle Park, NC
$47,978,469
Total funding
9
Grants
Funding over time
peak $15.3M · FY2005–09$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$47,978,469 · 9
By mechanism
U01$33,348,254 · 6
UC1$14,630,215 · 3
Investigators at Alphavax Human Vaccines, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Alphavirus Replicon Vaccines against Influenza$6,490,848
UC1 · FY2005 · AI
Development of Alphavirus Replicon Vaccine Against SARS$4,839,367
UC1 · FY2004 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*$3,577,242
U01 · FY2004 · AI
HIV Subtype C Alphavirus Vaccine Design &Development$3,529,060
U01 · FY2003 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses$3,373,441
U01 · FY2005 · AI
Development of an VEE Replicon Vaccine Against Smallpox$3,300,000
UC1 · FY2005 · AI
Alphavirus Replicon Vaccines against Marburg Virus$2,906,025
U01 · FY2003 · AI
HIV Subtype C Alphavirus Vaccine Design &Development$2,270,241
U01 · FY2002 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses$1,867,474
U01 · FY2004 · AI
Alphavirus Replicon Vaccines against Marburg Virus$1,843,827
U01 · FY2004 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*$1,799,459
U01 · FY2005 · AI
Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.$1,697,948
U01 · FY2007 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*$1,448,108
U01 · FY2006 · AI
Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.$1,396,158
U01 · FY2009 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*$1,344,570
U01 · FY2003 · AI
Alphavirus Replicon Vaccines against Marburg Virus$1,132,626
U01 · FY2002 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses$1,044,172
U01 · FY2006 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotoxin$878,891
U01 · FY2007 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses$840,848
U01 · FY2003 · AI
Dose Optimization, Production & Tox Testing of Replicon-Vaccines for Smallpox$500,000
U01 · FY2008 · AI